誉衡药业：国磊峰和西藏誉磐合计增持1.12%

Core Viewpoint - The company announced that its director, general manager, and financial officer Guo Leifeng, along with his concerted action partner Tibet Yupin, successfully acquired a total of 25 million shares in a judicial auction, representing 1.12% of the total share capital [1] Group 1 - Guo Leifeng increased his shareholding by acquiring 20 million shares, raising his total holdings to 41.98 million shares, which is 1.88% of the total [1] - Tibet Yupin acquired 5 million shares, bringing its total holdings to 5 million shares, or 0.22% of the total [1] - The combined shareholding of Guo Leifeng and Tibet Yupin amounts to 46.98 million shares, representing 2.10% of the total share capital [1]